InvestorsHub Logo
Followers 11
Posts 847
Boards Moderated 0
Alias Born 03/26/2011

Re: None

Wednesday, 02/08/2017 1:20:34 PM

Wednesday, February 08, 2017 1:20:34 PM

Post# of 27643
"In 2017 and beyond we will continue to simplify and reshape the company," Chief Executive Olivier Brandicourt told journalists. "We will be supported by our current growth engine businesses: Sanofi Genzyme, vaccines and consumer healthcare."

http://finance.yahoo.com/news/drugmaker-sanofi-sees-weak-2017-082546194.html

Keyword is SIMPLIFY and this is exactly the partnership is all about. IMO, Sanofi is aiming of simplifying the traditional method of making their virus-based vaccines to reduce time & costs as well as improving effectiveness not to mention the broad applicability of Mymetics' virosome-based VLP technology platform for various infectious diseases and immunotherapy for cancer, allergies, and autoimmune....

Note: Courtesy from Sanofi yahoo board


regards
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MYMX News